Everstar Asset Management’s Pfizer PFE Stock Holding History

Everstar Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	48,765 +1,570	+3%	+$41.1K	0.57%	56
2026 Q1	$1.33M	Buy	47,195 +948	+2%	+$25.2K	0.71%	40
2025 Q4	$1.15M	Buy	46,247 +4,997	+12%	+$126K	0.62%	42
2025 Q3	$1.05M	Buy	41,250 +6,967	+20%	+$172K	0.6%	48
2025 Q2	$831K	Buy	34,283 +14,504	+73%	+$338K	0.51%	53
2025 Q1	$501K	Sell	19,779 -1,014	-5%	-$26.5K	0.33%	96
2024 Q4	$552K	Buy	20,793 +594	+3%	+$16.1K	0.39%	64
2024 Q3	$585K	Buy	+20,199	New	+$589K	0.4%	73

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Everstar Asset Management's PFE Position: Q2 2026 in Review

Everstar Asset Management increased its Pfizer (PFE) stake by 3.3% in Q2 2026, buying an estimated $41.1K and bringing the position to 48,765 shares worth $1.17M. The position accounts for 0.57% of the portfolio, ranked #56.

Everstar Asset Management first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.33M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Everstar Asset Management held 48,765 shares of Pfizer worth $1.17M as of Q2 2026.
Everstar Asset Management bought 1,570 Pfizer shares in Q2 2026, an estimated $41.1K.
Pfizer made up 0.57% of Everstar Asset Management's portfolio in Q2 2026, its #56 holding.
Everstar Asset Management first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
Everstar Asset Management's Pfizer position peaked at $1.33M in Q1 2026.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Everstar Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.